NACDS President and CEO Steven C. Anderson issued the following statement, upon the release of a U.S. Department of Health and Human Services (HHS) Fact Sheet describing decision-making underway about implications of the May 11, 2023, expiration of the current Public Health Emergency (PHE).
While we all want to move on from COVID-19, doing so should not mean leaving behind millions of Americans who have relied on their trusted, local pharmacies for testing, vaccinations, and care during the pandemic.
With the U.S. House of Representatives slated to consider legislation related to the pandemic this week, NACDS has an important message: constituents view the importance of pharmacy access as a lesson that must be learned from the past three years.
The NACDS-authored column previews the policy outlook for the coming year — and what lies ahead for the future of the industry.
NACDS details actions needed by Biden Administration and Congress to prevent forced rollback
Sustaining PREP Act pharmacy flexibilities through October 2024 will help keep patients and pharmacies from having to “guess” about issues related to pharmacy access.
CNBC quoted NACDS on its call for the Biden Administration to maintain patients’ access to pharmacies in the effort to keep COVID-19 and flu at bay.
Hurricane Ian struck Florida as a powerful Category 4 hurricane on September 28, leaving widespread damage in its wake. NACDS member companies have been affected by the storm and—in collaboration with public health partners and emergency preparedness authorities— are working to meet the ongoing needs of people affected by the hurricane.
NACDS engages in White House Conference with commitments and recommendations, hosts “satellite event” to extend reach of event.
As COVID-19 preparedness enters a new phase, NACDS urges continuity of policies enabling pharmacies to provide key services patients expect and need.
